{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T22:55:50Z","timestamp":1769727350467,"version":"3.49.0"},"posted":{"date-parts":[[2023,11,22]]},"group-title":"Respiratory Medicine","reference-count":33,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,4,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:sec>\n                  <jats:title>Rationale<\/jats:title>\n                  <jats:p>Pulmonary innate immune cells play a central role in the initiation and perpetuation of chronic obstructive pulmonary disease (COPD), however the precise mechanisms that orchestrate the development and severity of COPD are poorly understood.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>We hypothesized that the recently described family of innate lymphoid cells (ILCs) play an important role in COPD.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>\n                    Subjects with COPD and healthy controls were clinically evaluated, and their sputum samples were assessed by flow cytometry. A mouse model of spontaneous COPD [genetically deficient in surfactant protein-D (SP-D\n                    <jats:sup>-\/-<\/jats:sup>\n                    )] and ozone (O\n                    <jats:sub>3<\/jats:sub>\n                    ) exposure were used to examine the mechanism by which lack of functional SP-D may skew ILC2s to produce IL-17A in combination with IL-5 and IL-13, leading to a mixed inflammatory profile and more severe disease.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Measurements and Main Results<\/jats:title>\n                  <jats:p>\n                    COPD was characterized by poor spirometry, sputum inflammation, and the emergence of sputum GATA3\n                    <jats:sup>+<\/jats:sup>\n                    ILCs (ILC2s), but not T-bet\n                    <jats:sup>+<\/jats:sup>\n                    ILCs (ILC1s) nor ROR\u03b3t\n                    <jats:sup>+<\/jats:sup>\n                    ILCs (ILC3s). COPD subjects with elevated sputum ILC2s (the ILC2\n                    <jats:sup>high<\/jats:sup>\n                    group) had worse spirometry and sputum neutrophilia and eosinophilia than healthy and ILC2\n                    <jats:sup>low<\/jats:sup>\n                    subjects. This was associated with the presence of dual-positive IL-5\n                    <jats:sup>+<\/jats:sup>\n                    IL-17A\n                    <jats:sup>+<\/jats:sup>\n                    and IL-13\n                    <jats:sup>+<\/jats:sup>\n                    IL-17A\n                    <jats:sup>+<\/jats:sup>\n                    ILCs and nonfunctional SP-D in the sputum in ILC2\n                    <jats:sup>high<\/jats:sup>\n                    subjects. SP-D\n                    <jats:sup>-\/-<\/jats:sup>\n                    mice showed spontaneous airway neutrophilia. Lack of SP-D in the mouse lung licensed ILC2s to produce IL-17A, which was dose-dependently inhibited by recombinant SP-D. SP-D\n                    <jats:sup>-\/-<\/jats:sup>\n                    mice showed enhanced susceptibility to O\n                    <jats:sub>3<\/jats:sub>\n                    -induced airway neutrophilia, which was associated with the emergence of inflammatory IL-13\n                    <jats:sup>+<\/jats:sup>\n                    IL-17A\n                    <jats:sup>+<\/jats:sup>\n                    ILCs.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We report that the presence of sputum ILC2s predicts the severity of COPD, and unravel a novel pathway of IL-17A plasticity in lung ILC2s, prevented by the immunomodulatory protein SP-D.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2023.11.21.23298837","type":"posted-content","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T15:15:11Z","timestamp":1700666111000},"source":"Crossref","is-referenced-by-count":3,"title":["COPD with elevated sputum group 2 innate lymphoid cells is characterized by severe disease"],"prefix":"10.64898","author":[{"given":"Cameron H.","family":"Flayer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela L.","family":"Linderholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moyar Q.","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Juarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Franzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Tham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Teuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Yi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schivo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooks","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Zeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Haczku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024040609050751000_2023.11.21.23298837v3.1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00142414"},{"key":"2024040609050751000_2023.11.21.23298837v3.2","doi-asserted-by":"publisher","DOI":"10.1038\/nature14189"},{"key":"2024040609050751000_2023.11.21.23298837v3.3","doi-asserted-by":"crossref","first-page":"e1287","DOI":"10.1002\/cti2.1287","article-title":"Quantification and role of innate lymphoid cell subsets in Chronic Obstructive Pulmonary Disease","volume":"10","year":"2021","journal-title":"Clinical & Translational Immunology"},{"key":"2024040609050751000_2023.11.21.23298837v3.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0282-9"},{"issue":"Suppl 5","key":"2024040609050751000_2023.11.21.23298837v3.5","first-page":"S263","article-title":"Type-2 innate lymphoid cells in asthma and allergy","volume":"11","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"2024040609050751000_2023.11.21.23298837v3.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.06.037"},{"key":"2024040609050751000_2023.11.21.23298837v3.7","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3443"},{"key":"2024040609050751000_2023.11.21.23298837v3.8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145961"},{"key":"2024040609050751000_2023.11.21.23298837v3.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2010.03483.x"},{"key":"2024040609050751000_2023.11.21.23298837v3.10","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1403042"},{"key":"2024040609050751000_2023.11.21.23298837v3.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.10.014"},{"key":"2024040609050751000_2023.11.21.23298837v3.12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.6.3557"},{"key":"2024040609050751000_2023.11.21.23298837v3.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2004.02134.x"},{"key":"2024040609050751000_2023.11.21.23298837v3.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.05.002"},{"key":"2024040609050751000_2023.11.21.23298837v3.15","doi-asserted-by":"crossref","unstructured":"Kierstein S , Poulain FR , Cao Y , Grous M , Mathias R , Kierstein G , Beers MF , Salmon M , Panettieri RA, Jr. , Haczku A . Susceptibility to ozone-induced airway inflammation is associated with decreased levels of surfactant protein D. Respir Res 2006; 7: 85.","DOI":"10.1186\/1465-9921-7-85"},{"key":"2024040609050751000_2023.11.21.23298837v3.16","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-9-13"},{"key":"2024040609050751000_2023.11.21.23298837v3.17","doi-asserted-by":"crossref","first-page":"L1005","DOI":"10.1152\/ajplung.00604.2020","article-title":"Increased serum SP-D in identification of high-risk smokers at high risk of COPD","volume":"320","year":"2021","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"key":"2024040609050751000_2023.11.21.23298837v3.18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.100448997"},{"key":"2024040609050751000_2023.11.21.23298837v3.19","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3078"},{"key":"2024040609050751000_2023.11.21.23298837v3.20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601421"},{"key":"2024040609050751000_2023.11.21.23298837v3.21","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M206200200"},{"key":"2024040609050751000_2023.11.21.23298837v3.22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0060266"},{"key":"2024040609050751000_2023.11.21.23298837v3.23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/JLB.3AB1117-455R","article-title":"Haczku Oxidative damage of SP-D abolishes control of eosinophil extracellular DNA trap formation","volume":"104","year":"2018","journal-title":"Journal of leukocyte biology"},{"key":"2024040609050751000_2023.11.21.23298837v3.24","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/15412555.2018.1476475","article-title":"Neutrophilic Inflammation in the Pathogenesis of Chronic Obstructive Pulmonary Disease","volume":"15","year":"2018","journal-title":"Copd"},{"key":"2024040609050751000_2023.11.21.23298837v3.25","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12660"},{"key":"2024040609050751000_2023.11.21.23298837v3.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60968-9"},{"key":"2024040609050751000_2023.11.21.23298837v3.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2016.10.008"},{"key":"2024040609050751000_2023.11.21.23298837v3.28","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwj078"},{"key":"2024040609050751000_2023.11.21.23298837v3.29","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3892\/etm.2016.2986","article-title":"Surfactant protein D, a clinical biomarker for chronic obstructive pulmonary disease with excellent discriminant values","volume":"11","year":"2016","journal-title":"Exp Ther Med"},{"key":"2024040609050751000_2023.11.21.23298837v3.30","doi-asserted-by":"publisher","DOI":"10.3109\/15412555.2012.736317"},{"key":"2024040609050751000_2023.11.21.23298837v3.31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-10-53"},{"key":"2024040609050751000_2023.11.21.23298837v3.32","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3308"},{"key":"2024040609050751000_2023.11.21.23298837v3.33","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12537"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2023.11.21.23298837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T19:45:21Z","timestamp":1768506321000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2023.11.21.23298837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,22]]},"references-count":33,"URL":"https:\/\/doi.org\/10.1101\/2023.11.21.23298837","relation":{},"subject":[],"published":{"date-parts":[[2023,11,22]]},"subtype":"preprint"}}